Keratocystic odontogenic tumor: clinical characteristics, diagnosis and possible treatments

Authors

Keywords:

keratocystic odontogenic tumor, keratocyst, Carnoy solution, marsupialization, Gorlin Goltz syndrome

Abstract

Introduction: the keratocystic odontogenic tumor is a locally aggressive tumor lesion with high recurrence described for the first time by Philipsen in 1956 under the name odontogenic keratocyst. It is believed that it comes from the remains of the dental lamina, but is not associated with a tooth. Objective: to describe the clinical and histological behavior of the keratocystic odontogenic tumor for the appropriate diagnosis and treatment or combination of treatments with less recurrence that allow a favorable long-term prognosis or its definitive resolution. Development: clinically it has a predilection for the posterior part of the body and mandibular branch, it invades the bone marrow and expands the bone cortices late, with perforation of the lingual cortical table being common. On radiological examination, it is an osteolytic, radiolucent lesion that occupies the posterior part of the body and mandibular ramus with a thin, well-defined cortex with smooth and scalloped margins. Histologically, it is characterized by a thin lining approximately 5 to 9 cells thick, palisade cells with a cuboidal appearance, presence of parakeratin on the luminal surface, absence of papillae and formation of satellite cysts. It is a highly recurrent lesion. The presence of multiple keratocysts is associated with a syndrome called nevoid basal cell syndrome or Gorlin Goltz syndrome. Final considerations: it constitutes an aggressive odontogenic tumor with a predilection for the jaw, it affects the quality of life of patients due to its high recurrence, there are several proposed treatments: marsupialization or decompression, enucleation with peripheral osteotomy, physical-chemical treatment and freezing.

Downloads

Download data is not yet available.

References

1. Arenas C. Nuevos conceptos en quistes de los tejidos duros y blandos de la cavidad oral. [Tesis]. Chile: Universidad de Chile, Facultad de Odontología; 1982.

2. Brad W, Neville DDS, Douglas D. DAMM, DDS+ and Thomas Brock, DDS+: Odontogenic Keratocyst of the Midline Maxillary Region. J Oral Maxillofac Surg. 1997; (55):340-44.

3. Pogrel MA. The Use of Liquid Nitrogen Cryotherapy in the management of locally aggressive bone lesions. J Oral Maxillofac Surg. 2015; (51):269-73.

4. Chow HT. Odontogenic Keratocyst: a clinical experience in Singapore. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86(5):573-7.

5. Fedotov SN, Minin EA. Experience with the treatment of Keratocyst of the jaws. Stomatologiia. 1999; 78(4):33-5.

6. García Pola M, González M, López JS. Quistes Odontogénicos de los Maxilares aspecto clínico-patológicos, diagnósticos y terapéuticos. Medicina Oral. 1997; (2):219-41.

7. Nish IA, Sánder GKB, Weinberg S. Extensive Odontogenic Keratocyst of the maxilla: cases review of the literature and report of six. Can J Plast Surg. 1997; 5(3):161-65.

8. Sosa SRD. Queratoquiste Odontogénico: Revisión de la literatura. Reporte de dos Casos Clínicos. Acta Odontol Venez [Internet]. 2002 Dic [citado 14 Sep 2023]; 40(3):276-281. Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0001-63652002000300005&lng=es

9. Díaz-Fernández JM, Infante-Cossío P, Belmonte-Caro R, Ruiz-Laza L, García-Perla-García A, Gutiérrez-Pérez JL. Basal cell nevus syndrome. Presentation of six cases and literature review. Med Oral Patol Oral Cir Bucal 2005; 10:E57-E66.

10. Kakarantza-Angelopoulou E, Nicalatou O. Odontogenic Keratocyst: Clinicopathologic study of 87 cases. J Oral Maxillofac Surg. 1970; (48):593.

11. Pauwels C, Mazereeuw-Hautier J, Basset-Seguin N, Livideanu C, Viraben R, Paul C, et al. Topical methyl aminolevulinate photodynamic therapy for management of basal cell carcinomas in patients with basal cell nevus syndrome improves patient's satisfaction and reduces the need for surgical procedures. J Eur Acad Dermatol Venereol [Internet]. 2011 [citado 14 Sep 2023]; 25: 861-864. Disponible en: http://dx.doi.org/10.1111/j.1468-3083.2010.03854.x

12. Micali G, Pasquale R de, Caltabiano R, Impallomeni R, Lacarrubba F. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report. J Dermatolog Treat [Internet]. 2002 [citado 14 Sep 2023]; 13: 123-127. http://dx.doi.org/10.1080/09546630260199488

13. Mohanty S, Dabas J, Verma A, Gupta S, Urs AB, Hemavathy S. Surgical management of the odontogenic keratocyst: A 20-year experience. Int J Oral Max Sur. 2021; 50(9):1168-1176.

14. Forteza-López A, Sáez-Alcaide LM, Molinero-Mourelle P, Helm A, Paz-Hermoso V de, Blanco-Jerez L, et al. Tratamiento del tumor odontogénico queratoquístico: revisión sistemática. Rev Esp Cirug Oral y Maxilofac [Internet]. 2019 Mar [citado 14 Sep 2023]; 41(1):26-32. Disponible en: https://dx.doi.org/10.20986/recom.2019.1026/2019

15. Polak K, Jędrusik-Pawłowska M, Drozdzowska B, Morawiec T. Odontogenic keratocyst of the mandible: A case report and literature review. Dental and medical problems. 2019; 56(4): 433-436.

Published

2023-10-30

How to Cite

1.
Narváez-Escobar MA, Miranda-Anchundia AK, Castillo-González JI. Keratocystic odontogenic tumor: clinical characteristics, diagnosis and possible treatments. Rev Inf Cient [Internet]. 2023 Oct. 30 [cited 2025 Apr. 2];102(2 Sup):4365. Available from: https://revinfcientifica.sld.cu/index.php/ric/article/view/4365